{
    "id": "yago_31586_3",
    "rank": 47,
    "data": {
        "url": "https://simplywall.st/stocks/id/healthcare/idx-mmix/multi-medika-internasional-shares/valuation",
        "read_more_link": "",
        "language": "en",
        "title": "Multi Medika Internasional (IDX:MMIX) Stock Valuation, Peer Comparison & Price Targets",
        "top_image": "https://simplywall.st/static/images/favicon-512x512.png",
        "meta_img": "https://simplywall.st/static/images/favicon-512x512.png",
        "images": [
            "https://simplywall.st/cdn-cgi/image/format=auto,fit=cover,w=135,q=80,blur=0/https://simplywall.st/static/legacy/images/landing/itunesbadge.png",
            "https://simplywall.st/cdn-cgi/image/format=auto,fit=cover,w=135,q=80,blur=0/https://simplywall.st/static/legacy/images/landing/googleplaysm.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Multi Medika Internasional",
            "IDX:MMIX",
            "MMIX",
            "IDX",
            "stock analysis",
            "news",
            "PE ratio",
            "intrinsic value",
            "DCF",
            "growth",
            "yield",
            "dividends"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "Research Multi Medika Internasional's (IDX:MMIX) stock key valuation metrics while comparing it with its industry peers & market side by side.",
        "meta_lang": "en",
        "meta_favicon": "https://simplywall.st/static/images/favicon-512x512.png",
        "meta_site_name": "Simply Wall St",
        "canonical_link": "https://simplywall.st/stocks/id/healthcare/idx-mmix/multi-medika-internasional-shares/valuation",
        "text": "Multi Medika Internasional Valuation\n\nIs MMIX undervalued compared to its fair value, analyst forecasts and its price relative to the market?\n\nValuation Score\n\n2/6\n\nValuation Score 2/6\n\nBelow Fair Value\n\nSignificantly Below Fair Value\n\nPrice-To-Sales vs Peers\n\nPrice-To-Sales vs Industry\n\nPrice-To-Sales vs Fair Ratio\n\nAnalyst Forecast\n\nShare Price vs Fair Value\n\nWhat is the Fair Price of MMIX when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.\n\nBelow Fair Value : Insufficient data to calculate MMIX's fair value for valuation analysis.\n\nSignificantly Below Fair Value : Insufficient data to calculate MMIX's fair value for valuation analysis.\n\nKey Valuation Metric\n\nWhich metric is best to use when looking at relative valuation for MMIX?\n\nOther financial metrics that can be useful for relative valuation.\n\nThe above table shows the n/a ratio for MMIX. This is calculated by dividing MMIX's market cap by their current preferred multiple.What is MMIX's n/a Ratio?n/a0xn/an/aMarket CapRp134.41b\n\nMMIX key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.Key StatisticsEnterprise Value/Revenue2xEnterprise Value/EBITDA21.2xPEG Ration/a\n\nPrice to Sales Ratio vs Peers\n\nHow does MMIX's PS Ratio compare to its peers?\n\nThe above table shows the PS ratio for MMIX vs its peers. Here we also display the market cap and forecasted growth for additional consideration.CompanyForward PSEstimated GrowthMarket CapPeer Average1.1x\n\nSDPC Millennium Pharmacon International\n\n0.05xn/aRp169.4b\n\nPEVE PT. Penta Valent\n\n0.1xn/aRp416.7b\n\nLABS UBC Medical Indonesia\n\n3.9xn/aRp525.4b\n\nZBRA Dosni Roha Indonesia\n\n0.3xn/aRp517.2b\n\nMMIX Multi Medika Internasional\n\n0.9xn/aRp134.4b\n\nPrice-To-Sales vs Peers : MMIX is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (1.1x).\n\nPrice to Earnings Ratio vs Industry\n\nHow does MMIX's PE Ratio compare vs other companies in the ID Healthcare Industry?\n\n0 CompaniesPrice / EarningsEstimated GrowthMarket CapIndustry Avg.n/a18.0% n/an/an/a\n\nNo. of CompaniesPS048121620\n\nFetching data\n\n0 CompaniesPrice / EarningsEstimated GrowthMarket CapIndustry Avg.n/a18.0% n/an/an/a\n\nNo more companies\n\nPrice-To-Sales vs Industry : MMIX is good value based on its Price-To-Sales Ratio (0.9x) compared to the ID Healthcare industry average (2.3x).\n\nPrice to Sales Ratio vs Fair Ratio\n\nWhat is MMIX's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.\n\nMMIX PS Ratio vs Fair Ratio.Fair RatioCurrent PS Ratio0.9xFair PS Ration/a\n\nPrice-To-Sales vs Fair Ratio : Insufficient data to calculate MMIX's Price-To-Sales Fair Ratio for valuation analysis.\n\nAnalyst Price Targets\n\nWhat is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?\n\nAnalyst Forecast : Insufficient data to show price forecast.\n\nDiscover undervalued companies\n\n7D\n\n1Y\n\n7D\n\n1Y\n\n7D\n\n1Y\n\nSimply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us."
    }
}